Intuitive Surgical stock trades at EUR 371.73 with USD 147.1 billion market cap

Published on 10/08/2026 at 19:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Intuitive Surgical stock costs EUR 371.73 on October 8, 2026. The prior close was EUR 370.65 and market value USD 147.1 billion.

Key points in brief

Lang & Schwarz quoted Intuitive Surgical at EUR 371.73 on October 8, 2026 at 7:02 p.m. CEST, plus 0.29 percent versus EUR 370.65.
The Nasdaq quote was USD 416.42 at 1:06 p.m. ET, while the 52-week range was USD 328.57 to USD 603.88.
Market capitalization stood at USD 147.1 billion and the P/E ratio was 47.34; Barclays set a USD 485.00 target on October 7, 2026.

Schwarzweiß-Reportagefoto eines Chirurgen an der Konsole während einer robotergestützten Operation — Dokumentarische Schwarzweiß-Reportage aus dem OP-Saal illustriert Intuitive Surgical Inc. (US46120E6023) und den Arbeitsalltag der Chirurgie-Robotik, Illustration mit AI erstellt.

Intuitive Surgical (ISIN US46120E6023) was trading at EUR 371.73 at Lang & Schwarz on October 8, 2026 at 7:02 p.m. CEST, plus 0.29 percent versus the prior close of EUR 370.65. The company had a USD 147.1 billion market capitalization, making that valuation the clearest benchmark for the current quote.

Euro quote and Nasdaq context

The euro quote was an after-hours indication under the Xetra session model. On Nasdaq, Intuitive Surgical was at USD 416.42 at 1:06 p.m. ET on October 8, 2026, with the US session open.

The primary-exchange price was 12.02 percent above the 52-week low of USD 328.57 and 31.10 percent below the 52-week high of USD 603.88. The range and Nasdaq price use the same currency and date, while the Lang & Schwarz quote remains the euro reference for German investors.

Valuation carries a high multiple

Intuitive Surgical traded at a P/E ratio of 47.34 on October 8, 2026. Its volume was 849,859 shares against an average volume of 2,915,559 shares, so turnover was 29.15 percent of that average during the available Nasdaq session.

According to Business Insider on October 7, 2026, Barclays maintained a Buy rating and set a USD 485.00 price target. That target lies 16.47 percent above the Nasdaq price of USD 416.42, using the two values in the same currency.

Comparison with peers

Intuitive Surgical: plus 0.29 percent, P/E 47.34, market capitalization USD 147.1 billion

Stryker (NYSE, USD): plus 0.06 percent, P/E 28.53, market capitalization USD 105.6 billion

Medtronic (NYSE, USD): plus 2.98 percent, P/E 21.69, market capitalization USD 112.7 billion

Next report date is October 20

Intuitive Surgical lists its Q3 2026 earnings conference call for October 20, 2026 at 1:30 p.m. PDT. The date gives the market a defined calendar point for the next company-specific update, while the current price report is centered on valuation and relative trading data.

Price remains below the yearly high

At EUR 371.73, Intuitive Surgical was 0.29 percent above its Lang & Schwarz prior close of EUR 370.65 on October 7, 2026. The further course of trading is shown by the continuously updated real-time quote of Intuitive Surgical stock.